C7orf33
geneOn this page
Summary
C7orf33 (chromosome 7 open reading frame 33, HGNC:21724) is a protein-coding gene on chromosome 7q36.1, encoding Uncharacterized protein C7orf33 (Q8WU49).
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 8 total — 2 pathogenic, 1 likely-pathogenic
- MANE Select transcript:
NM_145304
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21724 |
| Approved symbol | C7orf33 |
| Name | chromosome 7 open reading frame 33 |
| Location | 7q36.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000170279 |
| Ensembl biotype | protein_coding |
| Entrez | 202865 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000307003
RefSeq mRNA: 1 — MANE Select: NM_145304
NM_145304
CCDS: CCDS5890
Canonical transcript exons
ENST00000307003 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001133902 | 148615327 | 148615860 |
| ENSE00001133910 | 148590766 | 148591129 |
| ENSE00001172801 | 148614042 | 148614296 |
Expression profiles
Bgee: expression breadth tissue_specific, 9 present calls, max score 81.17.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0065 / max 9.3529, expressed in 1 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 81861 | 0.0065 | 1 |
Top tissues by expression
227 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.17 | gold quality |
| ganglionic eminence | UBERON:0004023 | 69.14 | gold quality |
| myocardium | UBERON:0002349 | 57.53 | gold quality |
| buccal mucosa cell | CL:0002336 | 57.28 | gold quality |
| cartilage tissue | UBERON:0002418 | 54.54 | gold quality |
| endothelial cell | CL:0000115 | 54.05 | gold quality |
| gingiva | UBERON:0001828 | 53.59 | gold quality |
| gingival epithelium | UBERON:0001949 | 53.36 | gold quality |
| heart right ventricle | UBERON:0002080 | 53.07 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 52.21 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 46.88 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 45.14 | gold quality |
| ventricular zone | UBERON:0003053 | 44.50 | silver quality |
| amniotic fluid | UBERON:0000173 | 44.31 | gold quality |
| synovial joint | UBERON:0002217 | 43.77 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 43.24 | gold quality |
| body of tongue | UBERON:0011876 | 43.21 | gold quality |
| vastus lateralis | UBERON:0001379 | 42.98 | gold quality |
| lower lobe of lung | UBERON:0008949 | 42.92 | silver quality |
| quadriceps femoris | UBERON:0001377 | 42.91 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| parotid gland | UBERON:0001831 | 42.38 | gold quality |
| biceps brachii | UBERON:0001507 | 42.21 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 41.79 | gold quality |
| bone marrow | UBERON:0002371 | 41.61 | gold quality |
| bone marrow cell | CL:0002092 | 41.57 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 41.48 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.81 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
21 targeting C7orf33, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-3180-5P | 99.82 | 69.12 | 2422 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-1303 | 99.65 | 69.77 | 1662 |
| HSA-MIR-4666B | 99.64 | 68.69 | 1282 |
| HSA-MIR-4437 | 99.52 | 65.29 | 1266 |
| HSA-MIR-889-3P | 99.40 | 69.76 | 2103 |
| HSA-MIR-32-3P | 99.36 | 68.20 | 2517 |
| HSA-MIR-130A-5P | 99.33 | 70.26 | 2623 |
| HSA-MIR-488-5P | 99.28 | 68.12 | 821 |
| HSA-MIR-5197-3P | 98.71 | 67.05 | 1905 |
| HSA-MIR-6852-3P | 98.54 | 67.60 | 1468 |
| HSA-MIR-138-5P | 98.43 | 70.49 | 1292 |
| HSA-MIR-499B-5P | 98.35 | 68.39 | 988 |
| HSA-MIR-3166 | 98.24 | 66.63 | 1223 |
| HSA-MIR-4685-3P | 97.55 | 67.35 | 1255 |
| HSA-MIR-4287 | 97.55 | 67.24 | 1247 |
| HSA-MIR-10400-3P | 97.29 | 64.66 | 597 |
| HSA-MIR-4674 | 97.29 | 64.62 | 597 |
| HSA-MIR-5684 | 93.17 | 64.85 | 454 |
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Uncharacterized protein C7orf33 — Q8WU49 (reviewed: Q8WU49)
All UniProt accessions (2): Q8WU49, A0A090N8Y1
RefSeq proteins (1): NP_660347* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR041287 | DUF5548 | Family |
Pfam: PF17702
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WU49-F1 | 32.20 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 34 (showing top):
NKX25_02, TGACCTY_ERR1_Q2, TAL1ALPHAE47_01, AAAYRNCTG_UNKNOWN, CAGCTG_AP4_Q5, HFH8_01, OCT1_07, TGANTCA_AP1_C, HFH1_01, FREAC4_01, TAL1BETAE47_01, FOX_Q2, ER_Q6_02, TAL1BETAITF2_01, MIR889_3P
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
154 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C7orf33 | DRC11L | A6NCM1 | 570 |
| C7orf33 | A0A087WTJ2 | A0A087WTJ2 | 514 |
| C7orf33 | ZNF425 | Q6IV72 | 507 |
| C7orf33 | ZBED10P | Q96FA7 | 507 |
| C7orf33 | ZNF786 | Q8N393 | 506 |
| C7orf33 | ZNF783 | Q6ZMS7 | 479 |
| C7orf33 | LRRC61 | Q9BV99 | 479 |
| C7orf33 | KRABD3 | A5PL33 | 478 |
| C7orf33 | WDR86 | Q86TI4 | 477 |
| C7orf33 | ZC3HAV1L | Q96H79 | 475 |
| C7orf33 | ZNF775 | Q96BV0 | 448 |
| C7orf33 | ZNF212 | Q9UDV6 | 447 |
| C7orf33 | TMEM213 | A2RRL7 | 445 |
| C7orf33 | ZNF862 | O60290 | 435 |
| C7orf33 | KLRG2 | A4D1S0 | 433 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| C7orf33 | PSMG3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| C7orf33 | TNNC2 | psi-mi:“MI:0914”(association) | 0.350 |
| INSR | RIMOC1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (4): C7orf33 (Positive Genetic), ACTA2 (Affinity Capture-MS), TNNC2 (Affinity Capture-MS), PSMG3 (Affinity Capture-MS)
ESM2 similar proteins: A0A1P8NVU1, A0A7H0DN35, A4TSL2, B2K870, B4F0U2, B9VXI8, C9J3V5, D3ZF18, F5HHT4, H3BU77, J3QM76, O89941, P05901, P0C8D9, P0CAQ7, P0DJX6, P0DJX7, P0DQF3, P0DW17, P14345, P16722, P19564, P21601, P22834, P24034, P36868, P59037, P61475, P64976, P86523, P9WLE4, P9WLE5, Q02781, Q10027, Q1C0B5, Q1CCJ5, Q1HVB5, Q2V4N5, Q495D7, Q497P3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
8 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 1 |
| Uncertain significance | 3 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (3)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2425899 | NC_000007.13:g.(?146471343)(148544390_?)del | Pathogenic |
| 833138 | NC_000007.14:g.(?147395589)(148847318_?)del | Pathogenic |
| 146688 | GRCh38/hg38 7q35-36.1(chr7:145999194-148860586)x1 | Likely pathogenic |
SpliceAI
289 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:148614041:GAA:G | acceptor_gain | 0.9900 |
| 7:148614038:CCA:C | acceptor_loss | 0.9800 |
| 7:148614039:CA:C | acceptor_loss | 0.9800 |
| 7:148614040:A:AG | acceptor_gain | 0.9800 |
| 7:148614040:A:G | acceptor_loss | 0.9800 |
| 7:148614041:G:GG | acceptor_gain | 0.9800 |
| 7:148614041:GA:G | acceptor_gain | 0.9800 |
| 7:148614041:GAAGC:G | acceptor_gain | 0.9700 |
| 7:148591127:AAGG:A | donor_loss | 0.9000 |
| 7:148591128:AGGTA:A | donor_loss | 0.9000 |
| 7:148591130:GTAA:G | donor_loss | 0.9000 |
| 7:148591131:T:G | donor_loss | 0.9000 |
| 7:148614022:T:A | acceptor_loss | 0.8700 |
| 7:148591130:G:GG | donor_gain | 0.8500 |
| 7:148614030:T:TA | acceptor_gain | 0.8500 |
| 7:148614044:GCCA:G | acceptor_gain | 0.7900 |
| 7:148615466:A:G | acceptor_gain | 0.7800 |
| 7:148603077:G:GT | donor_gain | 0.7600 |
| 7:148614038:CCAGA:C | acceptor_gain | 0.7300 |
| 7:148614039:CAGA:C | acceptor_gain | 0.7200 |
| 7:148614040:AGAA:A | acceptor_gain | 0.7200 |
| 7:148614041:GAAG:G | acceptor_gain | 0.7200 |
| 7:148590904:A:T | donor_gain | 0.7100 |
| 7:148591132:AA:A | donor_loss | 0.7000 |
| 7:148614044:GCC:G | acceptor_gain | 0.7000 |
| 7:148595197:C:CG | donor_gain | 0.6800 |
| 7:148591128:AG:A | donor_gain | 0.6700 |
| 7:148591129:GG:G | donor_gain | 0.6700 |
| 7:148593841:GC:G | donor_gain | 0.6700 |
| 7:148592238:C:A | donor_gain | 0.6600 |
AlphaMissense
1140 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:148614081:T:C | F82L | 0.939 |
| 7:148614083:T:A | F82L | 0.939 |
| 7:148614083:T:G | F82L | 0.939 |
| 7:148614129:T:C | F98L | 0.936 |
| 7:148614131:T:A | F98L | 0.936 |
| 7:148614131:T:G | F98L | 0.936 |
| 7:148591097:T:C | F58L | 0.922 |
| 7:148591099:T:A | F58L | 0.922 |
| 7:148591099:T:G | F58L | 0.922 |
| 7:148591098:T:C | F58S | 0.890 |
| 7:148591104:T:C | L60S | 0.875 |
| 7:148591065:T:A | V47D | 0.851 |
| 7:148614172:T:C | I112T | 0.832 |
| 7:148614282:A:C | S149R | 0.802 |
| 7:148614284:T:A | S149R | 0.802 |
| 7:148614284:T:G | S149R | 0.802 |
| 7:148590970:G:C | W15C | 0.796 |
| 7:148590970:G:T | W15C | 0.796 |
| 7:148591071:T:A | V49D | 0.775 |
| 7:148614130:T:C | F98S | 0.771 |
| 7:148614253:T:A | L139H | 0.755 |
| 7:148614125:G:C | W96C | 0.754 |
| 7:148614125:G:T | W96C | 0.754 |
| 7:148615379:T:C | I171T | 0.749 |
| 7:148591098:T:G | F58C | 0.734 |
| 7:148591104:T:G | L60W | 0.734 |
| 7:148614172:T:G | I112S | 0.728 |
| 7:148614258:T:G | Y141D | 0.728 |
| 7:148614263:G:C | K142N | 0.725 |
| 7:148614263:G:T | K142N | 0.725 |
dbSNP variants (sampled 300 via entrez): RS1000022594 (7:148592843 T>TA), RS1000239537 (7:148589526 C>T), RS1000311687 (7:148614405 G>A), RS1000398560 (7:148596148 T>C), RS1000461173 (7:148591176 A>C), RS1000548085 (7:148615771 A>G), RS1000619918 (7:148614149 G>A,C), RS1000707551 (7:148610171 T>G), RS1000802962 (7:148597227 A>G), RS1000827754 (7:148608813 T>C), RS1001128823 (7:148597584 A>G), RS1001304010 (7:148603936 C>A,T), RS1001310141 (7:148613358 C>A,T), RS1001419840 (7:148600967 T>C), RS1001497150 (7:148611359 A>G)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:610042
GenCC curated gene-disease
Mondo (1): cortical dysplasia-focal epilepsy syndrome (MONDO:0012400)
Orphanet (2): CNTNAP2-related developmental and epileptic encephalopathy (Orphanet:163681), OBSOLETE: Pitt-Hopkins-like syndrome (Orphanet:221150)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009391_201 | Metabolite levels | 5.000000e-06 |
| GCST009391_5 | Metabolite levels | 1.000000e-06 |
| GCST012490_516 | Femur bone mineral density x serum urate levels interaction | 4.000000e-10 |
| GCST90000015_11 | Parkinson’s disease motor subtype (tremor to postural instability/gait difficulty score ratio) | 3.000000e-06 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010488 | glycerol-3-phosphate measurement |
| EFO:0007813 | cotinine measurement |
| EFO:0004531 | urate measurement |
| EFO:0600011 | Parkinson’s disease symptom measurement |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C567657 | Cortical Dysplasia-Focal Epilepsy Syndrome (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, increases methylation | 2 |
| Folic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cortical dysplasia-focal epilepsy syndrome